D
Daniel Stadlbauer
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 51
Citations - 6850
Daniel Stadlbauer is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Hemagglutinin (influenza) & Vaccination. The author has an hindex of 21, co-authored 45 publications receiving 4077 citations. Previous affiliations of Daniel Stadlbauer include University of Natural Resources and Life Sciences, Vienna.
Papers
More filters
Journal ArticleDOI
A serological assay to detect SARS-CoV-2 seroconversion in humans.
Fatima Amanat,Daniel Stadlbauer,Shirin Strohmeier,Shirin Strohmeier,Thi H. O. Nguyen,Veronika Chromikova,Meagan McMahon,Kaijun Jiang,Guha Asthagiri Arunkumar,Denise Jurczyszak,Jose Polanco,Maria Bermudez-Gonzalez,Giulio Kleiner,Teresa Aydillo,Lisa Miorin,Daniel S. Fierer,Luz Amarilis Lugo,Erna Milunka Kojic,Jonathan Stoever,Sean T. H. Liu,Charlotte Cunningham-Rundles,Philip L. Felgner,Thomas M. Moran,Adolfo García-Sastre,Daniel Caplivski,Allen C. Cheng,Katherine Kedzierska,Olli Vapalahti,Jussi Hepojoki,Jussi Hepojoki,Viviana Simon,Florian Krammer +31 more
TL;DR: A serological enzyme-linked immunosorbent assay for the screening and identification of human SARS-CoV-2 seroconverters and can be adjusted to detect different antibody types in serum and plasma.
Journal ArticleDOI
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.
Ania Wajnberg,Fatima Amanat,Adolfo Firpo,Deena R. Altman,Mark J. Bailey,Mayce Mansour,Meagan McMahon,Philip Meade,Damodara Rao Mendu,Kimberly Muellers,Daniel Stadlbauer,Kimberly Stone,Shirin Strohmeier,Viviana Simon,Judith A. Aberg,David Reich,Florian Krammer,Carlos Cordon-Cardo +17 more
TL;DR: The vast majority of infected individuals with mild-to-moderate COVID-19 experience robust immunoglobulin G antibody responses against the viral spike protein, and titers are relatively stable for at least a period of about 5 months and that anti-spike binding titers significantly correlate with neutralization of authentic SARS-CoV-2.
Journal ArticleDOI
SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup.
Daniel Stadlbauer,Fatima Amanat,Veronika Chromikova,Kaijun Jiang,Shirin Strohmeier,Shirin Strohmeier,Guha Asthagiri Arunkumar,Jessica Tan,Disha Bhavsar,Christina Capuano,Ericka Kirkpatrick,Philip Meade,Ruhi Nichalle Brito,Catherine Teo,Meagan McMahon,Viviana Simon,Florian Krammer +16 more
TL;DR: A detailed protocol for expression of antigens derived from the spike protein of SARS‐CoV‐2 that can serve as a substrate for immunological assays, as well as a two‐stage serological enzyme‐linked immunosorbent assay (ELISA) can be used for research studies and for testing in clinical laboratories.
Journal ArticleDOI
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
Florian Krammer,Komal Srivastava,Hala Alshammary,Angela Amoako,Mahmoud Awawda,Katherine Beach,Maria Bermudez-Gonzalez,Dominika A. Bielak,Juan Manuel Carreño,Rachel Chernet,Lily Q. Eaker,Emily D. Ferreri,Daniel L. Floda,Charles R Gleason,Joshua Hamburger,Kaijun Jiang,Giulio Kleiner,Denise Jurczyszak,Julia C. Matthews,Wanni A. Mendez,Ismail Nabeel,Lubbertus C. F. Mulder,Ariel Raskin,Kayla T. Russo,Ashley Beathrese T. Salimbangon,Miti Saksena,Amber S. Shin,Gagandeep Singh,Levy A. Sominsky,Daniel Stadlbauer,Ania Wajnberg,Viviana Simon +31 more
TL;DR: In this article, the responses of seropositive persons to a single SARS-CoV-2 vaccine were surveyed and they reported that they had antibodies to the spike protein of SARS CoV2.
Posted ContentDOI
A serological assay to detect SARS-CoV-2 seroconversion in humans
Fatima Amanat,Daniel Stadlbauer,Shirin Strohmeier,Shirin Strohmeier,Thi H. O. Nguyen,Veronika Chromikova,Meagan McMahon,Kaijun Jiang,Guha Asthagiri Arunkumar,Denise Jurczyszak,Jose Polanco,Maria Bermudez-Gonzalez,Giulio Kleiner,Teresa Aydillo,Lisa Miorin,Daniel S. Fierer,Luz Amarilis Lugo,Erna Milunka Kojic,Jonathan Stoever,Sean T. H. Liu,Charlotte Cunningham-Rundles,Philip L. Felgner,Thomas M. Moran,Adolfo García-Sastre,Daniel Caplivski,Allen C. Cheng,Katherine Kedzierska,Olli Vapalahti,Jussi Hepojoki,Jussi Hepojoki,Viviana Simon,Florian Krammer +31 more
TL;DR: Serological assays are of critical importance to determine seroprevalence in a given population, define previous exposure and identify highly reactive human donors for the generation of convalescent serum as therapeutic.